- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. senior Avg
|
|
- 10-Q Quarterly report
- 10.4 EX-10.4 Change In Control Severance Agreement by and Between Treace Medical Concepts, Inc. and Daniel E. Owens
- 10.5 EX-10.5 Change In Control Severance Agreement by and Between Treace Medical Concepts, Inc. and Joe W. Ferguson
- 10.6 EX-10.6 Change In Control Severance Agreement by and Between Treace Medical Concepts, Inc. and Dipak A. Rajhansa
- 10.7 EX-10.7 Change In Control Severance Agreement by and Between Treace Medical Concepts, Inc. and Sean F. Scanlan
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Treace Medical Concepts, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: August 5, 2021 |
| By: | /s/ John T. Treace |
|
|
| John T. Treace |
|
|
| Chief Executive Officer (Principal Executive Officer) |